Interpath Global Expands Veterinary Focus Following Strong Growth of 4CYTE™
Interpath Global is expanding its investment in veterinary education and industry engagement following the successful launch and continued growth of 4CYTE™ Epiitalis® Forte Dog.
Originally developed to support joint health through Interpath’s patented plant seed oil Epiitalis®, the 4CYTE™ range has become one of Canada’s most recognised joint health brands, trusted by veterinarians, clinics, and pet owners alike.
While the brand has experienced strong organic growth over the past decade, Interpath is now increasing its focus on veterinary partnerships, education, and awareness initiatives across Canada.
“We’ve spent many years focused on research, product development, and delivering consistent outcomes in market,” said Rebecca Britton, CEO of Interpath Global.
